Chemogenomic Landscape of RUNX1-mutated AML Reveals Importance of RUNX1 Allele Dosage in Genetics and Glucocorticoid Sensitivity.Clin. Cancer Res. 2017-11-15;23(22):6969-6981.
MiSTIC, an integrated platform for the analysis of heterogeneity in large tumour transcriptome datasets.Nucleic Acids Res. 2017-07-27;45(13):e122.
A novel approach for the identification of efficient combination therapies in primary human acute myeloid leukemia specimens.Blood Cancer J 2017-02-17;7(2):e529.
MHC class I-associated peptides derive from selective regions of the human genome.J. Clin. Invest. 2016-12-01;126(12):4690-4701.
Expression of immunoproteasome genes is regulated by cell-intrinsic and -extrinsic factors in human cancers.Sci Rep 2016-09-23;6:34019.
Identification of MYC mutations in acute myeloid leukemias with NUP98-NSD1 translocations.Leukemia 2016-07-01;30(7):1621-4.
Chemo-genomic interrogation of CEBPA mutated AML reveals recurrent CSF3R mutations and subgroup sensitivity to JAK inhibitors.Blood 2016-06-16;127(24):3054-61.
Transcriptome analysis of G protein-coupled receptors in distinct genetic subgroups of acute myeloid leukemia: identification of potential disease-specific targets.Blood Cancer J 2016-06-03;6(6):e431.
Proteogenomic-based discovery of minor histocompatibility antigens with suitable features for immunotherapy of hematologic cancers.Leukemia 2016-06-01;30(6):1344-54.
RNA-sequencing analysis of core binding factor AML identifies recurrent ZBTB7A mutations and defines RUNX1-CBFA2T3 fusion signature.Blood 2016-05-19;127(20):2498-501.